What we do: Ginkgo Bioworks speeds up the process of genetically engineering and growing ingredients. We’ve built the first foundry for flexible industrialized organism engineering to develop a wide range of organisms for different markets. Integrating advanced software, robots and biology allow us to rapidly design, build, and test organisms until they meet our specifications.Why it's a big deal: Ginkgo led an $8M DOE project to engineer microbes that utilize single-carbon molecules. This technology is being used to capture natural gas being flared in North Dakota, and it could eventually lead to microbes converting these single-carbon compounds into fuel. Clearly, genetic engineering has immense potential to shape the future of this planet. Nature's biodiversity holds answers to challenges in health, energy, food, materials, and more. Ginkgo engineers develop new organisms that replace technology with biology, leading to 50% reductions in production costs for their clients. With contracts already signed for $10M in annual royalties, it's no wonder Ginkgo was able to pull in $9M from Series A financing. Ginkgo is expanding the role of biology in our world, uniting the creative aspects of biology and technology.
Ginkgo Bioworks is on Wefunder Inc. They are not conducting a Regulation Crowdfunding campaign. You can follow them and get notified of their progress.
Ask a Question5
Why you may want to support us...
Contracts signed for $10 million in annual royalties
Reduce production costs for customers by 50%
Grow ingredients in about 10 days
15 PhD’s and two MIT professors on staff
Raised $9 Million in Series A Financing
First biotech startup to go through Y Combinator
And Our Major Accomplishments
Barry has a PhD from MIT in Biological Engineering. He studied mechanical engineering at University College Dublin.
An MIT Professor, Tom has worked in computer science research for 40+ years. He has founded several computer tech companies.
Reshma was a biochemistry researcher at University of Cambridge. She has a PhD. in biological engineering from MIT after getting her B.S in Comp. Sci.
Austin studied Psychology and Computer Science at Stanford. He has a PhD. in Computer Science and Synthetic Biology from MIT.
By taking advantage of software-directed robots, the plan is to scale up the production of engineered organisms that could eventually be used to make anything from designer fragrances to cheap biofuels.
Ginkgo is part of a field called “synthetic biology” that holds immense promise — but also freaks people out. It involves writing genetic code and inserting it into simple organisms to change their function.
If microbes could be programmed as easily as software, the varieties of molecules used in foods, fragrances and other products would multiply–a vision that Ginkgo Bioworks Inc. aims to achieve after raising $9 million in Series A venture financing.
Gingko Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer microbes to convert CO2 emissions into fuel and is somehow making yeast smell like roses.
Wefunder supports three different federal laws that allow startups to raise money legally. To comply with the law, Wefunder Advisors LLC and Wefunder Portal LLC (both owned by Wefunder Inc) also list startups depending on the regulation used.
Legal May 16th 2016
Wefunder Portal LLC
for 251 startups
Wefunder Advisors LLC
for 98 startups
for 2 startups
Curious how well the companies have done? Or how many raised follow-on financing?
Some fine print: 1) These numbers include startups currently live on Wefunder if they pass their minimum target. 2) Some startups use two different laws at the same time (i.e., Regulation D and Regulation Crowdfunding).
Join 475,089 investors who funded 337 startups with over $119 million1
wefunder.com/ginkgobioworks is managed by
Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made.
Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA.
You may also view our Privacy Notice.
Wefunder, Inc., Wefunder Advisors LLC, and Wefunder Portal
LLC do not review user-generated content beyond what's
required by US law. Some user-generated content, including investor
biographical information, may not be accurate.